Tag: "cypher" at medical news

New study results suggest better outcomes with the CYPHER Stent than brachytherapy

WASHINGTON, D.C. - (October 17, 2005) - Results from the SISR trial, a multi-center, randomized study of the CYPHER(r) Sirolimus-eluting Coronary Stent versus radiation from within a vessel (brachytherapy) in patients with bare-metal in-stent reblockage (restenosis), were presented today at the Transcatheter Cardiovascular Therapeutics (TCT). ......2005) Scientific Symposium. The study showed tha...

Four-year data suggest the CYPHER stent provides long-term efficacy and safety benefits

ATLANTA -- March 11, 2006 - Patients treated with the CYPHER Sirolimus-eluting Coronary Stent continued to experience significantly better long-term clinical outcomes than those who received a bare metal stent (BMS), according to data presented today during a symposium at the 2006 American College of Cardiology Scientific Session....... The SIRIUS (Sirolimus-coated BX VELOCITY Balloon-Exp...

CYPHER Sirolimus-eluting Coronary Stent benefits from clinical success, worldwide growth in 2005

New data from a Spanish study presented at the 2005 American Heart Association Scientific Sessions found that patients with bifurcation lesions fared significantly better when treated with the CYPHER Sirolimus-eluting Coronary Stent compared with the Taxus stent in the areas of late loss, re-treatment (total lesion revascularization or TLR) and re-blockage (restenosis). Bifurcated lesions are dif...

Study finds patients with chronic total occlusions benefit from the CYPHER Stent

WASHINGTON, D.C. (October 18, 2005) Results from a study on chronic total occlusions in the coronary arteries show positive clinical outcomes in patients treated with the CYPHER Sirolimus-eluting Coronary Stent compared to those treated with conventional bare metal stents. ......The six-month clinical and angiographic findings of the PRISON II trial (A Prospective Randomized Trial of Sirolimus-...
(Date:10/30/2014)... therapeutics present unique challenges when it comes to ... harm. New consensus guidelines for toxicity testing that ... characteristics of these novel biopharmaceuticals are presented in ... from Mary Ann Liebert, Inc. publishers . ... Nucleic Acid Therapeutics website until November 30, ...
(Date:10/30/2014)... Oct. 29, 2014  Securus Technologies, a ... technology solutions for public safety, investigation, corrections ... deployed exciting enhancements to its THREADS™ product, ... provide actionable intelligence and focused leads for ... drive technological innovation through identifying and delivering ...
(Date:10/29/2014)... Beaverton, OR) New research presented at the ... in Houston, TX showed for the first time ... in women using a readily available nutritional supplement, ... by Dr. Judith A. Smith, Pharm.D., associate professor ... Sciences at The University of Texas Health Science ...
Breaking Biology News(10 mins):New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs 2Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2
Other Tags
bayermyrrhfabledcountersdiscussinginternetmicroarraystransformsandrogeleffectivenesrounddepressivefreshenersnavigationovershadowlebanon